Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO

Organogenesis Holdings (ORGO) Financial Statements

391 Followers

Organogenesis Holdings Financial Overview

Organogenesis Holdings's market cap is currently ―. The company's EPS TTM is $0.043; its P/E ratio is 74.19; Organogenesis Holdings is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 109.98M$ 99.65M$ 108.53M$ 117.32M$ 107.64M
Gross Profit$ 81.28M$ 71.88M$ 82.74M$ 117.32M$ 81.03M
EBIT$ -3.83M$ -1.29M$ 8.08M$ 9.77M$ -3.98M
EBITDA$ 2.35M$ 11.00M-$ 15.18M$ 1.89M
Net Income Common Stockholders$ -2.10M$ -568.00K$ 3.17M$ 5.32M$ -2.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.63M$ 103.84M$ 98.23M$ 89.51M$ 89.42M
Total Assets$ 458.48M$ 460.02M$ 462.65M$ 450.31M$ 446.11M
Total Debt$ 96.63M$ 98.98M$ 122.81M$ 122.67M$ 122.35M
Net Debt$ 8.00M$ -4.86M$ 24.59M$ 33.16M$ 32.94M
Total Liabilities$ 180.45M$ 181.36M$ 185.78M$ 179.03M$ 182.41M
Stockholders Equity$ 278.03M$ 278.66M$ 276.87M$ 271.28M$ 263.70M
Cash Flow-
Free Cash Flow$ -12.38M$ 7.29M-$ 1.15M$ -12.64M
Operating Cash Flow$ -10.16M$ 10.61M$ 16.73M$ 8.65M$ -5.08M
Investing Cash Flow$ -2.22M$ -3.32M$ -5.98M$ -7.50M$ -7.56M
Financing Cash Flow$ -2.61M$ -1.78M$ -1.44M$ -1.05M$ -1.24M
Currency in USD

Organogenesis Holdings Earnings and Revenue History

Organogenesis Holdings Debt to Assets

Organogenesis Holdings Cash Flow

Organogenesis Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis